Hubbard A R, Jennings C A, Barrowcliffe T W
Thromb Res. 1984 Sep 1;35(5):567-76. doi: 10.1016/0049-3848(84)90288-3.
The anticoagulant properties in vitro of eight heparan sulphate preparations were studied using clotting (APTT, anti-Xa) and amidolytic (anti-Xa, anti-thrombin) assays. Activities ranged from very low levels (less than 5 iu/mg) up to values similar to those of heparin. Activities measured by APTT assay showed the best correlation with the sulphate to carboxylate ratio of the heparan sulphates. Highest activities were obtained in the anti-Xa clotting assay, these being approximately two-fold greater than activities in the anti-Xa amidolytic assay. Five of the heparan sulphate preparations were readily neutralised by protamine sulphate, whereas the three heparans with the lowest sulphate to carboxylate ratio were much more resistant to neutralisation. After fractionating each heparan sulphate into At III-binding and non-binding material, it was found that the anti-coagulant properties were associated only with the former. It is concluded that these properties are dependent on the activation of At III.
使用凝血(活化部分凝血活酶时间[APTT]、抗Xa)和酰胺水解(抗Xa、抗凝血酶)试验研究了八种硫酸乙酰肝素制剂的体外抗凝血特性。活性范围从非常低的水平(低于5国际单位/毫克)到与肝素相似的值。通过APTT试验测得的活性与硫酸乙酰肝素的硫酸酯与羧基酯比率显示出最佳相关性。在抗Xa凝血试验中获得了最高活性,这些活性比抗Xa酰胺水解试验中的活性大约高两倍。五种硫酸乙酰肝素制剂很容易被硫酸鱼精蛋白中和,而硫酸酯与羧基酯比率最低的三种乙酰肝素对中和的抵抗力要强得多。将每种硫酸乙酰肝素分离成抗凝血酶III结合和非结合物质后,发现抗凝血特性仅与前者相关。得出的结论是,这些特性取决于抗凝血酶III的激活。